TY - JOUR
T1 - Ethnic differences in patterns of care of Stage 1A1 and Stage 1A2 cervical cancer
T2 - A SEER database study
AU - Del Carmen, Marcela G.
AU - Montz, F. J.
AU - Bristow, Robert E.
AU - Bovicelli, Alessandro
AU - Cornelison, T.
AU - Trimble, Edward
PY - 1999/10
Y1 - 1999/10
N2 - Objective. The aim of this study was to evaluate patterns of care for women with Stage 1A1 and 1A2 cervical cancer utilizing the SEER database. Methods. Review of SEER data from 11 registries from 1990 to 1995 was performed. Data from 2358 women were reviewed and stratified by substage, ethnicity, type of therapy, and age. Results. Three remarkable differences among subgroups were identified. (1) Among women ≥35 years of age, whites were more likely to have Stage 1A1 cancer than blacks or Hispanics; OR (95% CI) = 1.56 (1.05, 2.31) and 1.41 (1.04, 1.91), respectively. (2) Patients ≥35 years of age were more likely to undergo hysterectomy than younger patients both for 1A1 and 1A2 stages; OR (95% CI) = 2.31 (1.68, 3.19) and 2.78 (2.21, 3.50), respectively, with Mantel-Haenszel test of independence χ2 = 102.9943, P value < 0.001. (3) Black and Hispanic women ≥35 years of age with 1A2 disease were less likely to have a hysterectomy than whites. Only 15% of Hispanic patients and 9% of blacks over the age of 35 and with Stage 1A2 were treated via hysterectomy, compared to 76% of white women. Differences in hysterectomies for <35 years of age, 1A1 patients approached but did not reach statistical significance: blacks 36% versus Hispanic/whites 59%, P value = 0.07. Conclusions. Older white women were more likely to have cervical carcinoma diagnosed at an earlier stage (1A1) than age-matched blacks or Hispanics. Older patients, across all ethnic groups analyzed, were also more likely to be treated for both Stage 1A1 and 1A2 disease via hysterectomy than younger patients. Ethnic differences in the management of women with Stage 1A2 cervical cancer do exist: older minority women are less likely to have a hysterectomy and more likely to be treated via fertility- sparing, less definitive procedures than whites.
AB - Objective. The aim of this study was to evaluate patterns of care for women with Stage 1A1 and 1A2 cervical cancer utilizing the SEER database. Methods. Review of SEER data from 11 registries from 1990 to 1995 was performed. Data from 2358 women were reviewed and stratified by substage, ethnicity, type of therapy, and age. Results. Three remarkable differences among subgroups were identified. (1) Among women ≥35 years of age, whites were more likely to have Stage 1A1 cancer than blacks or Hispanics; OR (95% CI) = 1.56 (1.05, 2.31) and 1.41 (1.04, 1.91), respectively. (2) Patients ≥35 years of age were more likely to undergo hysterectomy than younger patients both for 1A1 and 1A2 stages; OR (95% CI) = 2.31 (1.68, 3.19) and 2.78 (2.21, 3.50), respectively, with Mantel-Haenszel test of independence χ2 = 102.9943, P value < 0.001. (3) Black and Hispanic women ≥35 years of age with 1A2 disease were less likely to have a hysterectomy than whites. Only 15% of Hispanic patients and 9% of blacks over the age of 35 and with Stage 1A2 were treated via hysterectomy, compared to 76% of white women. Differences in hysterectomies for <35 years of age, 1A1 patients approached but did not reach statistical significance: blacks 36% versus Hispanic/whites 59%, P value = 0.07. Conclusions. Older white women were more likely to have cervical carcinoma diagnosed at an earlier stage (1A1) than age-matched blacks or Hispanics. Older patients, across all ethnic groups analyzed, were also more likely to be treated for both Stage 1A1 and 1A2 disease via hysterectomy than younger patients. Ethnic differences in the management of women with Stage 1A2 cervical cancer do exist: older minority women are less likely to have a hysterectomy and more likely to be treated via fertility- sparing, less definitive procedures than whites.
KW - Cervical cancer
KW - Microinvasive
KW - SEER data
UR - http://www.scopus.com/inward/record.url?scp=0032878884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032878884&partnerID=8YFLogxK
U2 - 10.1006/gyno.1999.5543
DO - 10.1006/gyno.1999.5543
M3 - Article
C2 - 10502436
AN - SCOPUS:0032878884
SN - 0090-8258
VL - 75
SP - 113
EP - 117
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 1
ER -